Ekso Bionics to Become ChronoScale Corp. via Reverse Merger, Existing Shareholders Face 97% Dilution
summarizeSummary
Ekso Bionics shareholders approved a reverse merger with Applied Digital Cloud Corporation, resulting in 97% dilution for existing shareholders and a pivot to AI cloud services under the new name ChronoScale Corporation.
check_boxKey Events
-
Reverse Merger Approved
Shareholders approved a business combination where Ekso Bionics will acquire Applied Digital Cloud Corporation ('Cloud'), a subsidiary of Applied Digital Corporation, in exchange for 138,216,820 newly issued shares of Ekso common stock.
-
Massive Shareholder Dilution
Existing Ekso Bionics shareholders are expected to collectively hold approximately 3% of the combined company, ChronoScale Corporation, post-merger, representing a 97% dilution.
-
Company Rebranding and Business Pivot
Ekso Bionics Holdings, Inc. will be renamed 'ChronoScale Corporation' and will shift its primary business focus from exoskeletons to AI cloud services, trading under a new ticker symbol 'CHRN'.
-
New Majority Owner and Board Control
Applied Digital Corporation, through its subsidiary, will own approximately 96% of ChronoScale Corporation and will have the right to designate four out of seven directors, establishing it as a 'controlled company'.
auto_awesomeAnalysis
This filing details the definitive terms of a reverse merger that will fundamentally transform Ekso Bionics. While a 97% dilution was previously indicated in the company's 10-K, this PREM14C provides the crucial specifics and formal shareholder approval for the transaction. Existing shareholders will see their ownership reduced to approximately 3% of the combined entity, ChronoScale Corporation, which will pivot from exoskeletons to AI cloud services. The transaction addresses the company's previously disclosed 'going concern' warning by bringing in new capital and a new business, but at a severe cost to current equity holders through massive dilution and a loss of control to Applied Digital Corporation, which will hold 96% of the new company and control the board. This marks a complete change in the company's business model and ownership structure.
At the time of this filing, EKSO was trading at $10.69 on NASDAQ in the Technology sector, with a market capitalization of approximately $37.6M. The 52-week trading range was $2.73 to $13.50. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.